GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » OncoSec Medical Inc (FRA:ONMA) » Definitions » Cash Flow from Investing

OncoSec Medical (FRA:ONMA) Cash Flow from Investing : €0.00 Mil (TTM As of Jan. 2023)


View and export this data going back to 2015. Start your Free Trial

What is OncoSec Medical Cash Flow from Investing?

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

For the three months ended in Jan. 2023, OncoSec Medical spent €0.00 Mil on purchasing property, plant, equipment. It gained €0.00 Mil from selling property, plant, and equipment. It spent €0.00 Mil on purchasing business. It gained €0.00 Mil from selling business. It spent €0.00 Mil on purchasing investments. It gained €0.00 Mil from selling investments. It paid €0.00Mil for net Intangibles purchase and sale. And it paid €0.00 Mil for other investing activities. In all, OncoSec Medical gained €0.00 Mil on investment activities in financial market and operating subsidiaries for the three months ended in Jan. 2023.


OncoSec Medical Cash Flow from Investing Historical Data

The historical data trend for OncoSec Medical's Cash Flow from Investing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OncoSec Medical Cash Flow from Investing Chart

OncoSec Medical Annual Data
Trend Jul13 Jul14 Jul15 Jul16 Jul17 Jul18 Jul19 Jul20 Jul21 Jul22
Cash Flow from Investing
Get a 7-Day Free Trial Premium Member Only Premium Member Only -19.94 20.70 - -0.68 -0.24

OncoSec Medical Quarterly Data
Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23
Cash Flow from Investing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

OncoSec Medical Cash Flow from Investing Calculation

Cash Flow from Investing covers the cash a company gains or spends from investment activities in financial market and operating subsidiaries. It also includes the cash the company used for property, plant and equipment (PPE).

If a company spends cash on property, plant and equipment (PPE), this will reduce their cash position. This is called Capital Expenditures (CPEX).

Likewise, if a company buys another company for cash, this will reduce their cash position.

OncoSec Medical's Cash Flow from Investing for the fiscal year that ended in Jul. 2022 is calculated as:

OncoSec Medical's Cash Flow from Investing for the quarter that ended in Jan. 2023 is calculated as:


Cash Flow from Investing for the trailing twelve months (TTM) ended in Jan. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OncoSec Medical  (FRA:ONMA) Cash Flow from Investing Explanation

Cash flow from investing contains nine items:

1. Purchase Of Property, Plant, Equipment:
Purchase of PPE indicates the amount used to purchase property, plant, and equipment.

OncoSec Medical's purchase of property, plant, equipment for the three months ended in Jan. 2023 was €0.00 Mil. It means OncoSec Medical spent €0.00 Mil on purchasing property, plant, equipment.

In the capital spending for property, plant and equipment (PPE), some part of spending may be from the expansion of business. The business needs more property, plant and equipment (PPE) as it grows. Another part may be from replacement of the property, plant and equipment (PPE) of existing business. For some companies, the cash spent on replacing of the property, plant and equipment (PPE) of the existing business will be close to the depreciation of property, plant and equipment (PPE) reported in the income statement.

In Warren Buffett's definition of Owner's Earnings, he deducts the estimate of the cost of replacing the property, plant and equipment (PPE) of the existing business from cash flow from operations. The cash spent on the new property, plant, and equipment is not deducted. The reason is because these are not costs of the existing business. In his 1986 letter to shareholders, Warren Buffett wrote this about owner earnings:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume....Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

2. Sale Of Property, Plant, Equipment:
Sale of PPE indicates the amount gained from selling property, plant, and equipment.

OncoSec Medical's sale of property, plant, equipment for the three months ended in Jan. 2023 was €0.00 Mil. It means OncoSec Medical gained €0.00 Mil from selling property, plant, and equipment.

3.Purchase Of Business:
Purchase of business indicates the amount used to purchase business.

OncoSec Medical's purchase of business for the three months ended in Jan. 2023 was €0.00 Mil. It means OncoSec Medical spent €0.00 Mil on purchasing business.

4. Sale Of Business:
Sale of business indicates the amount gained from selling business.

OncoSec Medical's sale of business for the three months ended in Jan. 2023 was €0.00 Mil. It means OncoSec Medical gained €0.00 Mil from selling business.

5. Purchase Of Investment:
Purchase of Investments represents cash outflow on the purchase of investments in securities.

OncoSec Medical's purchase of investment for the three months ended in Jan. 2023 was €0.00 Mil. It means OncoSec Medical spent {stock_data.stock.currency_symbol}}0.00 Mil on purchasing investments.

6. Sale Of Investment:
Sale of Investments represents cash inflow on the sale of investments in securities.

OncoSec Medical's sale of investment for the three months ended in Jan. 2023 was €0.00 Mil. It means OncoSec Medical gained €0.00 Mil from selling investments.

7. Net Intangibles Purchase And Sale:
Net Intangibles purchase and sale means the net cash inflow received by a company that comes from the purchase and sale of intangibles. It equals the cash received from sale of intangibles minus the cash spent on purchasing intangibles.

OncoSec Medical's net Intangibles purchase and sale for the three months ended in Jan. 2023 was €0.00 Mil. It means OncoSec Medical paid €0.00 Mil for net Intangibles purchase and sale.

8. Cash From Discontinued Investing Activities:
Cash from discontinued investing activities means the cash received by a company that comes from the discontinued investing activities.

OncoSec Medical's cash from discontinued investing activities for the three months ended in Jan. 2023 was 0.00 Mil. It means OncoSec Medical paid €0.00 Mil for discontinued investing activities.

9. Cash From Other Investing Activities:
Cash from other investing activities means the cash received by a company that comes from other investing activities.

OncoSec Medical's cash from other investing activities for the three months ended in Jan. 2023 was €0.00 Mil. It means OncoSec Medical paid €0.00 Mil for other investing activities.


OncoSec Medical Cash Flow from Investing Related Terms

Thank you for viewing the detailed overview of OncoSec Medical's Cash Flow from Investing provided by GuruFocus.com. Please click on the following links to see related term pages.


OncoSec Medical Business Description

Traded in Other Exchanges
N/A
Address
24 North Main Street, Pennington, NJ, USA, 08534
OncoSec Medical Inc is a healthcare sector company. It is focused on designing, developing and commercializing gene therapies, therapeutics, and medical approaches to stimulate an anti-tumor immune response for the treatment of cancer. The company's lead product candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor through in vivo electroporation. In addition, it is pursuing ImmunoPulse IL-12 monotherapy in patients with triple-negative breast cancer.

OncoSec Medical Headlines

No Headlines